Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study.
Navarro-Pérez MP, González-Quintanilla V, Muñoz-Vendrell A, Madrigal E, Alpuente A, Latorre G, Molina F, Monzón MJ, Medrano V, García-Azorín D, González-Oria C, Gago-Veiga A, Velasco F, Beltrán I, Morollón N, Viguera J, Casas-Limón J, Rodríguez-Vico J, Cuadrado E, Irimia P, Iglesias F, Guerrero-Peral ÁL, Belvís R, Pozo-Rosich P, Pascual J, Santos-Lasaosa S.
Navarro-Pérez MP, et al. Among authors: madrigal e.
Front Neurol. 2024 Jun 13;15:1417831. doi: 10.3389/fneur.2024.1417831. eCollection 2024.
Front Neurol. 2024.
PMID: 38938776
Free PMC article.